Skip to main content
Clinical Trials/IRCT20190506043492N3
IRCT20190506043492N3CompletedPhase 3

Investigation of the effect of N-acetyl cysteine on renal function after coronary artery bypass graft surgery

Ahvaz University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
30 years to 70 years (—)
Sex
All

Inclusion Criteria

  • Candidates for open heart surgery.
  • Be 30 to 70 years old.
  • Have normal kidney and liver functionDo not have thyroid disease, hypertension, diabetes and arrhythmia.
  • Don't be addicted to drugs.
  • Glomerular filtration should be less than 60.

Exclusion Criteria

  • The patient is not satisfied to participate in the study.
  • If the patient is taking renal effective drugs such as steroids and anti-inflammatory.
  • If you are allergic to N-acetyl cysteine.

Investigators

Similar Trials